GlaxoSmithKline is investing in artificial intelligence (AI) with the hope of radically cutting the time and money needed to develop a drug. It has entered into an alliance with Exscientia ...

In a report released on January 9, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing informa ...

Painkiller brands Panadol and Anadin will be bought under one roof under a giant deal between drug firms GlaxoSmithKline and Pfizer. The firms are combining their consumer healthcare businesses ...

News for GlaxoSmithKline Consumer Healthcare Ltd. Google.org Grants $1 Million to Karya for AI Upskilling in India Google.org awards USD 1 million to Karya, an Indian non-profit, to empower low-income ...

Pharmaceutical company GlaxoSmithKline (GSK) has announced it is to shut its antibiotics business at two UK sites. The firm is selling its Zinnat operation to Swiss-owned Sandoz, which will ...

Speaking on behalf of the CEOs of the 13 pharmaceutical companies involved, Sir Andrew Witty, CEO of GlaxoSmithKline, said, “Many companies and organisations have worked for decades to fight these ...

Despite promising Phase II data, there was no difference in overall survival between the patients who received Canvaxin and the patients who received placebo in the randomized Phase III trial of ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...